Jason has extensive experience negotiating 340B-related agreements, including those involving covered entities, contract pharmacies, administrators, payers, and others.
Mark focuses his practice primarily on regulatory matters involving pharmaceutical pricing and, specifically, the 340B federal drug discount program.
00:00:00.017 --> 00:00:05.237
Welcome to the 340 Banter podcast. Today, we're joined by Mark Ogunshusi,
00:00:05.537 --> 00:00:07.697
as well as Jason Reddish from Powers Law.
00:00:08.097 --> 00:00:12.577
We'll be discussing recent legal arguments pharmaceutical manufacturers have
00:00:12.577 --> 00:00:17.677
been using inside the courts, as well as what we see coming down the road in litigation.
00:00:18.357 --> 00:00:22.857
Even though Mark and Jason are lawyers, you should not use this as legal advice
00:00:22.857 --> 00:00:24.617
and should consult general counsel.
00:00:45.157 --> 00:00:49.737
All right. So 340B has been really rampant in the courtrooms lately,
00:00:49.917 --> 00:00:51.737
both at the state and the federal level.
00:00:51.857 --> 00:00:55.237
So I was wondering if we could kind of go through today and get your insights
00:00:55.237 --> 00:00:59.617
from the legal perspective, both of us being pharmacists, and maybe go through
00:00:59.617 --> 00:01:02.937
some of the arguments that have come up in those court cases lately.
00:01:03.617 --> 00:01:06.137
Yeah, I mean, that sounds like a good idea, but we're going to keep it,
00:01:06.157 --> 00:01:08.077
you know, related to pharmacists.
00:01:08.417 --> 00:01:11.657
We're not talking to lawyers, we're talking to pharmacists. It was a lot easier
00:01:11.657 --> 00:01:15.697
when there were only like two 340B cases for the first 30 years to keep track of.
00:01:16.037 --> 00:01:19.097
Oh, yeah. Well, we talked about, you know, going through case by case,
00:01:19.157 --> 00:01:21.317
but we would be here for weeks. So we're going to go back.
00:01:21.557 --> 00:01:23.917
And we would need a lot of paper in front of us, which would not be helpful.
00:01:23.917 --> 00:01:25.237
We'll go by arguments instead at this point.
00:01:25.997 --> 00:01:30.097
So let's kick us off. I think preemption is one of the first ones that had come up.
00:01:30.257 --> 00:01:34.077
You want to talk us kind of through what that is and how that's played out in the court cases so far.
00:01:34.157 --> 00:01:38.137
Yeah. So my pharmacists out there, we're dealing with these state laws that
00:01:38.137 --> 00:01:40.757
require drugs to be shipped to your pharmacies.
00:01:41.677 --> 00:01:46.897
And, you know, the drug makers, manufacturers don't like these state laws because
00:01:46.897 --> 00:01:52.197
they require that these discounted medications that safety net providers provide
00:01:52.197 --> 00:01:53.537
are shipped to your pharmacies.
00:01:53.617 --> 00:01:58.437
And they're saying, no, federal law is the absolute, because 340 is a federal
00:01:58.437 --> 00:02:01.177
pricing statute, right? That's where the price occurs.
00:02:01.437 --> 00:02:04.457
Say it's absolute, leaves no room for state law. So therefore,
00:02:04.737 --> 00:02:06.077
it preempts the state law.
00:02:06.297 --> 00:02:09.577
So any state law relating to delivery, and we all know there's all sorts of
00:02:09.577 --> 00:02:13.377
state laws relating to delivery, wholesaler laws and things of that nature,
00:02:13.517 --> 00:02:15.397
controlled substance laws related to distribution.
00:02:16.585 --> 00:02:21.905
Somehow, spontaneously, a federal pricing statute allegedly preempts or supplants
00:02:21.905 --> 00:02:27.025
or should take the place of or cancels out the state law. And that's preemption.
00:02:27.465 --> 00:02:30.305
So that's the argument. I don't know if you wanted to get into the disposition
00:02:30.305 --> 00:02:35.245
of these cases. So I think we've seen a lot of success at the state level.
00:02:35.485 --> 00:02:39.545
And so obviously that argument is not working.
00:02:39.765 --> 00:02:45.645
Is that what we're seeing? Yeah, at the federal court level,
00:02:45.785 --> 00:02:51.465
but looking at state laws, they've found that the 340B statute doesn't address delivery.
00:02:51.825 --> 00:02:57.345
It addresses pricing and addresses some other aspects of acquiring the drugs,
00:02:57.365 --> 00:03:01.125
but it doesn't speak to whether drugs have to be shipped to a certain place
00:03:01.125 --> 00:03:06.185
or whether manufacturers have to ship to where the covered entity wants them to be shipped.
00:03:06.745 --> 00:03:10.205
So the preemption arguments have largely fallen flat.
00:03:10.725 --> 00:03:14.985
They were also hurt a little bit because on the cases that challenged whether
00:03:14.985 --> 00:03:19.225
manufacturers could impose restrictions on contract pharmacy restrictions,
00:03:19.405 --> 00:03:22.685
their whole argument is, well, there's a huge gap in the statute. It just says offer.
00:03:22.865 --> 00:03:25.905
So we can fill that gap. If there's a huge gap in the statute,
00:03:26.105 --> 00:03:28.985
it obviously doesn't occupy all of the 340B field.
00:03:29.125 --> 00:03:33.605
And there was room for state regulation in areas that states typically regulate shipments.
00:03:33.985 --> 00:03:36.545
I want to add to what Jason's name is. we're talking to pharmacists, right?
00:03:36.985 --> 00:03:40.565
I mean, how complex is the practice of pharmacy? How many variations do we see?
00:03:40.905 --> 00:03:45.245
We see institutional pharmacy at hospitals. We see retail pharmacies.
00:03:45.365 --> 00:03:48.225
We see long-term care pharmacies. We see infusion pharmacies.
00:03:48.785 --> 00:03:52.345
And state laws govern the practice of pharmacy. In fact, Jason,
00:03:52.865 --> 00:03:54.965
does the 340 statute even mention the term pharmacy?
00:03:55.165 --> 00:03:57.225
No, the word pharmacy is not used anywhere. Not once.
00:03:57.565 --> 00:04:00.165
So why are the drug makers saying that the federal law preempts the state law?
00:04:00.285 --> 00:04:04.225
I don't know. I don't know. All right. Well, then we'll move on from preemption.
00:04:05.025 --> 00:04:09.865
Next one we've seen is the Dormant Commerce Clause. I mean, that's a mouthful.
00:04:10.045 --> 00:04:12.165
The Dormant Commerce Clause.
00:04:12.405 --> 00:04:16.565
Long story short, for my pharmacists out there, they believe these state delivery
00:04:16.565 --> 00:04:21.865
laws regulate Honda transactions occurring completely out of the state.
00:04:22.025 --> 00:04:26.905
It's an old constitutional law concept that interstate commerce,
00:04:26.905 --> 00:04:28.585
the federal government can regulate.
00:04:28.785 --> 00:04:33.645
And they're saying that a state law that requires the drug maker to not block
00:04:33.645 --> 00:04:37.545
or limit delivery of these discounted drugs to the pharmacies,
00:04:37.725 --> 00:04:41.085
to your pharmacy, regulates out-of-state conduct.
00:04:41.425 --> 00:04:47.125
You know, the drug makers just spontaneously, after years of delivering drugs into states,
00:04:47.705 --> 00:04:52.405
now states can't regulate these deliveries because some drug makers are located
00:04:52.405 --> 00:04:55.245
in that state, some drug makers are located in that state, but at the end of
00:04:55.245 --> 00:04:57.605
the day, they know their drugs are getting to your state.
00:04:57.985 --> 00:05:02.525
And again, that's another argument that I think is a bit spurious, spurious, spurious,
00:05:03.073 --> 00:05:07.373
You know, I haven't seen a new word for me. Well, it's unreasonable.
00:05:10.693 --> 00:05:15.973
It's well, it's unreasonable. I mean, it's like these are old constitutional
00:05:15.973 --> 00:05:18.493
contentions that have never gone anywhere.
00:05:18.713 --> 00:05:23.793
And there's plenty of case law establishing that states can regulate delivery
00:05:23.793 --> 00:05:25.273
of drugs within their borders. Yeah.
00:05:25.413 --> 00:05:30.073
And so, you know, what we've seen is failure by the drug makers on that.
00:05:30.153 --> 00:05:32.693
In fact, they're dropping those claims, that claim. They're not really even
00:05:32.693 --> 00:05:33.933
included in their litigation.
00:05:34.313 --> 00:05:38.753
And there are plenty of state laws that have impacts on activities outside of the state.
00:05:38.873 --> 00:05:42.513
I mean, one thing I use, I think of often when you're talking about this,
00:05:42.693 --> 00:05:46.033
it's called the Dormant Commerce Clause because the idea is if the federal government
00:05:46.033 --> 00:05:49.353
can regulate commerce between the states, then states can't do anything that
00:05:49.353 --> 00:05:51.013
hinders commerce between states.
00:05:51.093 --> 00:05:53.613
Yeah, that makes sense. But you think about, we watched game shows growing up.
00:05:53.693 --> 00:05:55.693
You've got the California emission standards.
00:05:55.913 --> 00:05:58.453
Like every car was up to the California emission standards.
00:05:58.853 --> 00:06:02.193
They're the biggest market. If they set an emission standard and they're allowed
00:06:02.193 --> 00:06:05.553
to under state law, that's going to affect everybody out of state because they're
00:06:05.553 --> 00:06:08.453
probably going to go down to that standard to be able to ship drugs to,
00:06:08.633 --> 00:06:09.933
I mean, ship cars to California.
00:06:10.553 --> 00:06:14.633
So it's not unusual for a state to have a minimum standard for their own state
00:06:14.633 --> 00:06:17.453
that is going to affect people who want to ship into the state.
00:06:17.453 --> 00:06:21.293
As long as it applies equally to a drug manufacturer in Arkansas as it does
00:06:21.293 --> 00:06:23.733
to one in New York, then there's not really an impact. Yeah,
00:06:23.893 --> 00:06:24.913
that's a great explanation.
00:06:26.218 --> 00:06:29.158
All right. So the next one we've got is due process takings.
00:06:29.358 --> 00:06:34.718
So this is what they're really kind of focusing on lately, which is that,
00:06:34.838 --> 00:06:35.718
you know, the government,
00:06:36.058 --> 00:06:41.238
state or federal government can't take private property from private individuals
00:06:41.238 --> 00:06:43.438
or entities without just compensation.
00:06:43.918 --> 00:06:47.858
And so I mentioned we have this is all about the 340B federal pricing statute.
00:06:47.858 --> 00:06:49.598
That's nothing about delivery or distribution.
00:06:50.118 --> 00:06:55.078
But they're alleging that because the statute sets a price that these coverings
00:06:55.078 --> 00:06:58.658
can pay and the state law says you must deliver it to where the coverings say
00:06:58.658 --> 00:07:01.518
you should deliver it, that that's taking their property.
00:07:01.638 --> 00:07:04.958
They have patents and they should be able to set their prices unreasonably high.
00:07:05.078 --> 00:07:09.058
I'm not going to get crazy, but we know drug makers are 300 to 1,000 percent
00:07:09.058 --> 00:07:11.158
in the United States and the other developed country in the world.
00:07:11.158 --> 00:07:15.458
We know we're being screwed here in the United States, but they're saying that
00:07:15.458 --> 00:07:17.958
that's a taking and that they weren't justly compensated.
00:07:18.598 --> 00:07:21.918
But, you know, the counterargument to that, similar to with the inflation reduction
00:07:21.918 --> 00:07:24.438
for my pharmacist, Medicare negotiated prices,
00:07:25.038 --> 00:07:30.478
discounted Medicare drugs, is that the drug makers voluntarily participate in
00:07:30.478 --> 00:07:34.098
the 340B program so that their drugs are covered under Medicare and Medicaid.
00:07:34.298 --> 00:07:37.658
The business decision at the end of the day. Well, it's a really good business decision.
00:07:38.258 --> 00:07:41.978
How much taxpayer, I mean, how much money do you think these companies are making
00:07:41.978 --> 00:07:45.838
off of Medicare and Medicaid in exchange for giving some safety net providers
00:07:45.838 --> 00:07:48.298
critical discounts to keep our country moving?
00:07:48.738 --> 00:07:54.138
Billions and billions of dollars. Have we seen that actually go through any
00:07:54.138 --> 00:07:58.358
court cases yet? Has it been successful? Actually, on the Inflation Reduction
00:07:58.358 --> 00:08:00.718
Act side, it's been rejected repeatedly.
00:08:00.918 --> 00:08:04.098
The taking cost. And it actually makes a lot more sense on that side,
00:08:04.238 --> 00:08:08.298
where they say, I've got this patent window, and now you're telling me that
00:08:08.298 --> 00:08:13.178
I have to submit to your price, basically, or pay an incredibly high tax.
00:08:14.218 --> 00:08:16.938
And if I don't, my only other option is drop out of Medicare.
00:08:17.398 --> 00:08:19.918
And so they're saying we're being hijacked to do it.
00:08:19.998 --> 00:08:23.838
And the counter argument is Medicare is the biggest drug market in the world.
00:08:24.098 --> 00:08:27.338
It's one of the best payers in the world. If you want access to that market,
00:08:27.498 --> 00:08:28.958
you have to play by that market's rules.
00:08:29.478 --> 00:08:34.298
And for the most part, that is that is largely succeeded and knocked down the
00:08:34.298 --> 00:08:35.278
manufacturer arguments.
00:08:35.578 --> 00:08:40.138
You know, whether the IRA survives a change in in the House or presidency is
00:08:40.138 --> 00:08:44.198
probably a bigger conversation or whether it survives with changes is probably a bigger conversation.
00:08:44.218 --> 00:08:48.178
But the due process arguments have not gotten them over the finish line.
00:08:48.478 --> 00:08:51.218
You can't take what you're voluntarily participating in.
00:08:51.558 --> 00:08:54.938
Yeah, there's an option that the manufacturers could choose to not be part of
00:08:54.938 --> 00:08:58.498
the pharmacy pricing agreement, which would remove them from Medicaid and Medicare,
00:08:58.738 --> 00:09:03.638
but would also remove them from the 340B program. PBM contracts are terrible.
00:09:03.858 --> 00:09:07.698
You could choose not to contract with the major PBMs. You won't be able to run
00:09:07.698 --> 00:09:09.278
a pharmacy, but you could choose that.
00:09:09.578 --> 00:09:13.698
Well, yeah, of course. I think one thing to add on to the PBM situation,
00:09:13.698 --> 00:09:17.518
if I'm a pharmacy, is that I'm not, by signing this PBM contract,
00:09:17.658 --> 00:09:20.658
making billions and billions of taxpayer dollars.
00:09:20.978 --> 00:09:25.038
I mean, these drug companies are making massive amounts by, you know,
00:09:25.178 --> 00:09:28.858
participating in the 340B program because their drugs are covered under a separate
00:09:28.858 --> 00:09:32.598
program, Medicare, Medicaid, and other programs. I mean, they're killing it.
00:09:32.698 --> 00:09:35.778
I mean, I mean, anyways, I'm not going to get into it. They make a lot of money.
00:09:35.858 --> 00:09:36.698
Let's just put it that way.
00:09:37.438 --> 00:09:40.338
Really? I didn't get that message. They're doing okay. Stop punching down.
00:09:40.658 --> 00:09:44.958
Okay. All right. So we'll move on to the contracts clause. The next one we're seeing.
00:09:45.478 --> 00:09:48.918
Yeah, this one's pretty simple. The drug makers are saying, you know,
00:09:49.058 --> 00:09:52.078
by requiring us to deliver drugs to where the patients can actually pick them
00:09:52.078 --> 00:09:57.058
up, you're modifying our contracts with, let's say, wholesalers or other contracts that they have.
00:09:57.358 --> 00:10:02.978
And, you know, again, none of these claims have won in any federal court. You know, they're.
00:10:03.533 --> 00:10:09.653
Untenable propositions that, you know, really would upset decades-long practice.
00:10:09.953 --> 00:10:11.433
You know, there's plenty of regulations
00:10:11.433 --> 00:10:13.833
on it. Let's talk about state-controlled substance laws, right?
00:10:14.073 --> 00:10:18.313
That modifies a wholesaler contract. You know, there's plenty of state laws
00:10:18.313 --> 00:10:21.113
that have impacts on your contracts.
00:10:21.233 --> 00:10:25.473
The bottom line is states are free to protect public health and safety within their borders.
00:10:25.793 --> 00:10:31.073
And, you know, I hope the drug makers get with the public health program and
00:10:31.073 --> 00:10:32.833
stop these spurious arguments.
00:10:33.473 --> 00:10:36.533
Yeah, I mean, contracts clause is a tough thing to argue. Basically,
00:10:36.613 --> 00:10:40.653
there's a line in the Constitution that says no state shall impair the obligation of contracts.
00:10:40.973 --> 00:10:45.393
But that could be like, I'm going to pass a law that says Logan Yoho doesn't
00:10:45.393 --> 00:10:49.133
owe his mortgage to that bank in Ohio anymore. You're lucky that. Yeah.
00:10:51.033 --> 00:10:55.753
It's not, there are a lot of exceptions in balancing tests when you're imposing
00:10:55.753 --> 00:11:00.673
regulations that help health and safety that happen to have an impact on existing contracts.
00:11:00.933 --> 00:11:04.593
So one of the things I like about talking through these arguments and explaining
00:11:04.593 --> 00:11:10.053
them to somebody that's not a lawyer is that what we're seeing is that in some
00:11:10.053 --> 00:11:13.133
states they're considering this, but there's fears of this litigation.
00:11:13.133 --> 00:11:18.673
So it's really good that we're discussing this and showing that these arguments
00:11:18.673 --> 00:11:19.593
haven't been successful.
00:11:19.813 --> 00:11:23.533
I think there's value there. And we went from Louisiana, I mean,
00:11:23.553 --> 00:11:28.953
Arkansas to Arkansas and Louisiana to Arkansas, Louisiana, Maryland,
00:11:29.053 --> 00:11:34.133
Mississippi, Missouri, Minnesota, Kansas, West Virginia in like three and a half, four years.
00:11:34.293 --> 00:11:38.433
And there were probably another five or six states that there was fear.
00:11:38.633 --> 00:11:41.873
Well, we don't want to get sued or we're afraid that we'll get pulled into this litigation.
00:11:42.213 --> 00:11:47.333
Every time one of these states wins, it makes it easier and easier to pass a law in another state.
00:11:47.513 --> 00:11:50.933
So maybe we go from eight now to 15 next year. Yeah.
00:11:51.493 --> 00:11:55.053
Especially if there's fear about what's going to happen at the federal level.
00:11:55.213 --> 00:11:59.013
Yeah, I think that could play in as a positive at the state level.
00:11:59.133 --> 00:12:01.653
Yeah, when you read the opinions, the judges aren't even...
00:12:02.498 --> 00:12:05.278
I mean, they're duly considering the drug maker's arguments,
00:12:05.278 --> 00:12:09.098
but they're, you know, they're slapping them down back and forth.
00:12:09.338 --> 00:12:13.418
So really, we're just talking about multinational, highly profitable companies
00:12:13.418 --> 00:12:14.638
that have the money to sue,
00:12:14.918 --> 00:12:18.518
to slow down enforcement against them so that they continue to drive up shareholder
00:12:18.518 --> 00:12:21.598
value and make more money, money, money, money on the backs of our community
00:12:21.598 --> 00:12:24.278
pharmacies, on the backs of our patients who are in underserved communities,
00:12:24.458 --> 00:12:28.898
on the backs of our safety net providers and public health providers throughout the country. Yeah.
00:12:29.178 --> 00:12:32.238
I'm going to take us to an argument that's not a constitutional argument,
00:12:32.358 --> 00:12:37.738
but one we're seeing come up, I think, a lot more recently is the kind of questioning
00:12:37.738 --> 00:12:40.158
the replenishment system and maintaining the title of the drug.
00:12:40.758 --> 00:12:44.418
Yeah, so that fits within a constitutional argument. It fits within,
00:12:44.578 --> 00:12:48.238
you know, AstraZeneca is alleging that in Arkansas, for example.
00:12:48.498 --> 00:12:52.658
But it fits within the due process takings, like taking property without just
00:12:52.658 --> 00:12:54.098
compensation, like patented property.
00:12:54.358 --> 00:12:57.838
And it fits within the preemption. They're saying that the 340 statute says
00:12:57.838 --> 00:13:01.698
a covered entity, the safety net provider who's entitled to purchase the drug,
00:13:01.858 --> 00:13:06.098
shall not transfer the drug to anyone other than a person, a patient,
00:13:06.258 --> 00:13:07.398
a patient of the covered entity.
00:13:07.558 --> 00:13:09.818
Yes. Right. Which has been around since the beginning of time.
00:13:10.158 --> 00:13:14.318
So the drug makers are saying replenishment, you know, where the drug is dispensed,
00:13:14.598 --> 00:13:19.098
a drug is dispensed, and a drug replenishes the drug, that's all I'm going to say about it,
00:13:19.458 --> 00:13:22.938
violates the transfer prohibition, and it's a taking of their property,
00:13:23.038 --> 00:13:25.438
their discounted drugs. Now, let's just think about it.
00:13:26.642 --> 00:13:29.502
Replenishment it's just an inventory accounting system first in
00:13:29.502 --> 00:13:32.362
first out yada yada has been around since before
00:13:32.362 --> 00:13:35.662
establishment of the united states it's well established
00:13:35.662 --> 00:13:38.642
that when a party is
00:13:38.642 --> 00:13:44.182
has some inventory especially fungible goods you know you don't have to account
00:13:44.182 --> 00:13:48.522
with detailed particularity one product versus another product they're fungible
00:13:48.522 --> 00:13:51.602
they're inter place they're interchangeable for example when i put money into
00:13:51.602 --> 00:13:55.642
the bank and the bank mixes that money up with all the other money in the bank.
00:13:55.782 --> 00:13:57.862
That doesn't mean the bank automatically owns your money.
00:13:58.302 --> 00:14:01.442
The bank is just holding that money on your behalf. You're also not getting
00:14:01.442 --> 00:14:04.162
the exact same, you know, dollar bill back.
00:14:04.622 --> 00:14:07.442
Yeah, you're not getting the serial number. Yeah. Well, yeah.
00:14:07.602 --> 00:14:09.822
And look, I'm not going to get into the legal arguments, but at the end of the
00:14:09.822 --> 00:14:14.902
day, and Jason probably wants to talk more about this, after decades-long practice,
00:14:15.022 --> 00:14:17.342
replenishment systems were used before 340B was enacted.
00:14:17.642 --> 00:14:22.942
Under Nonprofit Institution Act, for example, for, you know, own-use hospitals.
00:14:23.542 --> 00:14:28.082
You know, the thing is, is that after 30 years of practice or more,
00:14:28.342 --> 00:14:32.142
these drug companies are now all of a sudden saying, you know,
00:14:32.262 --> 00:14:34.642
we've been dealing with this, this has been going on.
00:14:34.942 --> 00:14:38.622
It's even more accurate than physically separating the product because you trace
00:14:38.622 --> 00:14:40.622
each drug on an 11-digit.
00:14:40.722 --> 00:14:44.122
Every pill that goes out, you make sure that went to a patient, right?
00:14:44.362 --> 00:14:47.982
They're saying that now it's illegal. Just so you can understand how we feel
00:14:47.982 --> 00:14:51.142
in the covered in the community after 30 years, all of a sudden,
00:14:51.222 --> 00:14:53.642
oh, no, that's illegal. No, you guys are taking my property.
00:14:54.282 --> 00:14:58.922
And actually, it's a good segue into everything that manufacturers are looking
00:14:58.922 --> 00:15:00.902
at that maybe they haven't challenged before.
00:15:01.182 --> 00:15:05.362
A lot of people don't know that pharma filed suit against HRSA in 1996 when
00:15:05.362 --> 00:15:08.782
the first contract pharmacy guidance came out and they actually pulled it back
00:15:08.782 --> 00:15:10.782
because of pushback from Ryan White Clinics.
00:15:11.500 --> 00:15:16.340
So, you know, they were they had an opportunity when this was announced in 1996
00:15:16.340 --> 00:15:20.660
to litigate it and fight over whether the program allowed contract pharmacies.
00:15:20.860 --> 00:15:26.000
They didn't. Now they come back literally 24 years later and they start self-imposing
00:15:26.000 --> 00:15:27.500
some restrictions on the program.
00:15:27.700 --> 00:15:33.260
Does that impact their, I don't know, have a leg to stand on when you're making
00:15:33.260 --> 00:15:36.440
that argument when you've not challenged it for 25 years?
00:15:36.440 --> 00:15:40.420
There is a legal concept. It's called latches, which literally means you delayed
00:15:40.420 --> 00:15:43.900
so long that it's unfair to the person that you're trying to enforce it against.
00:15:44.100 --> 00:15:47.880
It doesn't apply as often when you're dealing with challenging a government
00:15:47.880 --> 00:15:49.800
aspect, but it is a factor.
00:15:49.980 --> 00:15:53.220
I mean, that you voluntarily participated in this model.
00:15:53.480 --> 00:15:58.880
You knew who you were shipping the drugs to for 20 years and you didn't balk at it then.
00:15:59.500 --> 00:16:02.680
But manufacturers are trying to challenge the replenishment model.
00:16:02.680 --> 00:16:07.440
If you think about risk-reward for them, if they were somehow able to get rid
00:16:07.440 --> 00:16:11.140
of replenishment, you would cut the contract pharmacy market in half.
00:16:11.320 --> 00:16:13.700
You would have problems with hospitals and split billing.
00:16:13.980 --> 00:16:17.820
Yeah, hospitals wouldn't be able to manage their clinic-administered or physician-administered
00:16:17.820 --> 00:16:20.460
drugs. They would have to severely limit where they can use 340B.
00:16:20.580 --> 00:16:23.160
And a lot of health centers, even their entity-owned pharmacies,
00:16:23.160 --> 00:16:26.640
are virtual in nature. Depending on Medicaid carve-out and things like that,
00:16:26.700 --> 00:16:29.900
you may have single neutral inventory there.
00:16:30.100 --> 00:16:36.320
Yeah. So you're talking about maybe cutting the volume of 340B purchasing nationwide by $30 billion.
00:16:36.940 --> 00:16:41.660
And they're going to spend some money to try that. And it's not for the purpose. Let's just be clear.
00:16:42.100 --> 00:16:47.040
It's not for the purpose of greater, you know, we don't want this because it'll
00:16:47.040 --> 00:16:51.300
be more accurate if you maintain a separate inventory. Because the second you
00:16:51.300 --> 00:16:55.080
dispense a drug out of a physically separate inventory to a non-patient,
00:16:55.300 --> 00:16:56.700
that's diversion, right?
00:16:56.820 --> 00:17:01.500
There's no opportunity to true up. There's no opportunity to account for the
00:17:01.500 --> 00:17:03.440
pills that are fungible, that are mixable.
00:17:03.800 --> 00:17:07.420
So it really is just an opportunity to do what Jason is saying,
00:17:07.980 --> 00:17:08.780
challenging replenishment.
00:17:09.000 --> 00:17:14.140
It's just to save money. It's just to make money. It's just a multinational profit.
00:17:14.440 --> 00:17:18.060
Or to make things more complicated to the point that you can no longer comply.
00:17:18.300 --> 00:17:24.240
And therefore, you can charge your extremely 300 to 1,000% high list price drugs. Yeah. Anyways.
00:17:24.620 --> 00:17:27.740
All right. Right. So I've got one more constitutional argument for us to hit
00:17:27.740 --> 00:17:32.860
on that's been seen in some of the cases we've seen so far, but seems to be less frequent now.
00:17:33.700 --> 00:17:37.320
Unconstitutional vagueness, which sounds to me just pretty, pretty vague.
00:17:37.520 --> 00:17:40.760
Like it seems like it's pretty self-explanatory. story yeah yeah
00:17:40.760 --> 00:17:43.420
the bottom line is if you're going to
00:17:43.420 --> 00:17:46.340
punish somebody for violating a law they have to know what they're
00:17:46.340 --> 00:17:50.820
prohibited from doing so you know if you have a law in the books that says anybody
00:17:50.820 --> 00:17:56.060
who is is performing vagrancy will be charged with a misdemeanor and you ask
00:17:56.060 --> 00:17:59.200
somebody what is vagrancy and they come up with whatever decision they whatever
00:17:59.200 --> 00:18:02.320
definition they want that's going to be unconstitutionally vague can't create
00:18:02.320 --> 00:18:03.740
a criminal record for someone because.
00:18:06.126 --> 00:18:11.826
Manufacturers have tried to argue that some of the language in these state statutes
00:18:11.826 --> 00:18:14.246
is unconstitutionally vague.
00:18:14.466 --> 00:18:17.426
And I think they've been shut out. I know they've been shut out on those.
00:18:17.546 --> 00:18:20.046
And I think they've stopped really raising that argument.
00:18:20.386 --> 00:18:23.626
Yeah, I think they've stopped raising the argument. If you want an opinion,
00:18:23.766 --> 00:18:28.806
you can look at the Louisiana lawsuits, plural with Pharma and AstraZeneca,
00:18:29.166 --> 00:18:32.486
that they lost with flying colors because the law is pretty clear.
00:18:33.026 --> 00:18:36.426
But unconstitutional vagueness, I mean, a law that says you must not limit delivery
00:18:36.426 --> 00:18:38.046
of a product is pretty concrete.
00:18:38.226 --> 00:18:41.966
I mean, what they want you to do, what they want to do is obfuscate very clear
00:18:41.966 --> 00:18:47.326
laws such that they can create grounds to invalidate them and make more money.
00:18:47.486 --> 00:18:49.506
But at the end of the day, don't limit delivery.
00:18:49.706 --> 00:18:54.406
Your policy specifically references distribution and limiting distribution and
00:18:54.406 --> 00:18:55.426
or prohibiting distribution.
00:18:55.926 --> 00:19:00.066
And that's pretty concrete. And that's why the unconstitutional vagueness argument
00:19:00.066 --> 00:19:03.626
has not, you know, it doesn't have legs. It hasn't had any legs.
00:19:03.926 --> 00:19:08.226
Courts basically have said, you know, under basic case law, we can read the
00:19:08.226 --> 00:19:10.646
statute in a way that's concrete. Right.
00:19:10.846 --> 00:19:13.766
I mean, if you're writing statutes for a state, if you're helping work on a
00:19:13.766 --> 00:19:16.286
bill for your state, you can have it in the back of your mind.
00:19:16.306 --> 00:19:20.406
But the Legislative Council, one of their jobs when they prepare a bill for
00:19:20.406 --> 00:19:23.766
the state is to look for constitutional issues. And that's always going to be
00:19:23.766 --> 00:19:24.606
something they look for.
00:19:24.806 --> 00:19:28.506
So it's already gone through a layer before it gets passed of somebody deciding
00:19:28.506 --> 00:19:30.066
it's not vague. All right.
00:19:30.226 --> 00:19:33.906
So now I kind of want to pivot. And we've talked about the arguments that we've
00:19:33.906 --> 00:19:38.566
seen that are going on in the courtroom right now or have been and say,
00:19:38.726 --> 00:19:41.006
looking forward, what what can we expect?
00:19:41.146 --> 00:19:43.866
Are we going to see some, you know, a lot of the same arguments,
00:19:44.026 --> 00:19:48.206
a lot of the same issues? Are we going to see some new issues coming up? I think new issues.
00:19:48.466 --> 00:19:52.366
So two things that we've been dealing with, and really one of them is now a
00:19:52.366 --> 00:19:57.346
year old, is manufacturers, at least one manufacturer, seeking and obtaining
00:19:57.346 --> 00:20:03.106
permission from HRSA to audit a health center for Medicaid managed care duplicate discounts. Yeah.
00:20:05.559 --> 00:20:09.999
More than a decade, Hearst has said, we don't have any jurisdiction over managed care.
00:20:10.319 --> 00:20:12.759
We're not going to issue. At one point, they said, we're going to issue policy
00:20:12.759 --> 00:20:15.959
in conjunction with CMS on managed care. Then they came back and said, no, we're not.
00:20:16.339 --> 00:20:20.059
Just kidding. Yeah. And the statute itself is written in a way that treats fee-for-service
00:20:20.059 --> 00:20:21.219
differently than managed care.
00:20:21.539 --> 00:20:25.659
When they expanded the rebate program to include managed care in 2010,
00:20:25.979 --> 00:20:29.579
they included a provision that said if the drug's purchased on a 340B account
00:20:29.579 --> 00:20:32.899
and billed to a managed care plan, it's not eligible for a rebate.
00:20:33.099 --> 00:20:37.019
We're only prohibited from billing Medicaid for drugs that are eligible for a rebate.
00:20:37.279 --> 00:20:40.159
So they kind of took it all away from 340B and HRSA.
00:20:40.559 --> 00:20:43.579
It was a big shock. We fought pretty hard.
00:20:43.879 --> 00:20:48.619
HRSA did not relent. They allowed this manufacturer to audit the covered entity.
00:20:48.799 --> 00:20:53.019
The audit actually took place about seven months ago. We still don't have a response.
00:20:53.219 --> 00:20:57.679
They rode this health center hard to make them submit documents and move along.
00:20:57.819 --> 00:21:03.059
And we're not really sure why suddenly HRSA, which has never issued any position
00:21:03.059 --> 00:21:07.739
of its own on managed care, is now letting a drug manufacturer essentially make up the rules.
00:21:08.079 --> 00:21:12.059
Because if there's no rule from HRSA to look at, what rule is the manufacturer?
00:21:12.199 --> 00:21:19.679
And a lot of states have very vague language on how to prevent a rebate in the MCO space.
00:21:19.679 --> 00:21:24.119
Yeah. In this particular case, during the time period, there was no rule for
00:21:24.119 --> 00:21:27.759
managed care claims at the state level and none at the payer level either.
00:21:27.759 --> 00:21:29.719
So I have two follow-ups with that, right?
00:21:29.819 --> 00:21:34.519
So you're saying that's a potential dispute in the future, maybe against HRSA
00:21:34.519 --> 00:21:38.619
for permitting the audit by the drugmaker in the first instance,
00:21:38.699 --> 00:21:41.979
or even obligating the covered entity in any way to be involved in something
00:21:41.979 --> 00:21:42.799
that's not responsible for.
00:21:42.799 --> 00:21:45.639
So my question is, who is responsible?
00:21:45.859 --> 00:21:48.779
So firstly, what you just said made it seem to me, and correct me if I'm wrong.
00:21:49.299 --> 00:21:54.979
That once a covered entity chooses to purchase a 340B drug, the rebateability
00:21:54.979 --> 00:21:57.219
of the drug is extinguished.
00:21:57.339 --> 00:22:01.899
So therefore, the state can't request a rebate once the covered entity chooses to purchase the drug.
00:22:01.959 --> 00:22:06.879
Is that right? Well, the state can write laws and impose rules on when a 340B
00:22:06.879 --> 00:22:09.419
entity can use 340B drugs to bill MCOs.
00:22:09.559 --> 00:22:13.259
They can do that through their contracts with the MCOs and tell the MCOs,
00:22:13.339 --> 00:22:16.779
you're going to tell pharmacies they cannot use 340B drugs.
00:22:16.799 --> 00:22:21.819
Or they can issue a statewide regulation or even pass a law that says you can't
00:22:21.819 --> 00:22:25.359
use 340B drugs when you bill managed care. A lot of states haven't done anything.
00:22:26.238 --> 00:22:31.038
There's nothing on the books about how to do it. And you look at each MCO contract
00:22:31.038 --> 00:22:32.918
or manual and there's nothing there.
00:22:33.078 --> 00:22:37.218
It's so hard to find information. I know we work with health centers all over
00:22:37.218 --> 00:22:43.098
the country to find information about even what MCOs, what PBM they're using.
00:22:43.598 --> 00:22:48.278
And sometimes you find a bulletin and it's just posted on a website somewhere.
00:22:48.518 --> 00:22:53.378
And the lawyer will say, this tears up all of my managed care contracts,
00:22:53.378 --> 00:22:56.378
this bulletin that they just posted. There's no notice and comment.
00:22:56.638 --> 00:23:01.058
There was no official process. They just put a notice on the website and now
00:23:01.058 --> 00:23:04.478
I'm supposed to give up $5 million in managed care bill.
00:23:04.618 --> 00:23:08.078
I mean, it hasn't been handled well in many states.
00:23:08.318 --> 00:23:12.118
Some states have, but in many states it was pretty much ignored.
00:23:12.378 --> 00:23:14.938
And then it got to be a bigger problem for manufacturers.
00:23:15.258 --> 00:23:18.278
And I think HRSA doesn't really know what to do at this point.
00:23:18.278 --> 00:23:22.698
Well, so my question is around the manufacturer audit in HRSA,
00:23:22.878 --> 00:23:26.038
I guess it could be looked at one of two ways.
00:23:26.158 --> 00:23:31.518
Either, you know, condoned it or didn't present a strong front to it.
00:23:31.878 --> 00:23:38.338
Is the timing of kind of Chevron deference in HRSA having less of a say,
00:23:38.798 --> 00:23:41.338
potentially, you know, playing into that?
00:23:41.338 --> 00:23:45.678
I mean, this is actually an area where they have some statutory cover,
00:23:45.838 --> 00:23:50.338
where the statute says that they can, manufacturers can audit under the basically
00:23:50.338 --> 00:23:53.538
conditions that the secretary, which is HRSA, allows.
00:23:53.798 --> 00:23:58.178
So they actually had a little bit of strength here where they put out a policy
00:23:58.178 --> 00:24:01.338
in accordance with notice and comment that may actually have some...
00:24:02.283 --> 00:24:07.163
Some legal effect. Now, somebody else could look at it now, post-Chevron means
00:24:07.163 --> 00:24:10.263
a judge could look at it and reach their own interpretation of what that means.
00:24:10.763 --> 00:24:15.763
But I think this, it could have been a political call that, you know,
00:24:15.903 --> 00:24:21.103
this manufacturer has been beat up pretty bad by HHS on the IRA and some other
00:24:21.103 --> 00:24:22.603
things, so let's let them have this.
00:24:22.843 --> 00:24:24.963
It could have just been a poor decision.
00:24:25.303 --> 00:24:28.563
Or it could be a strategic, we're going to move in this direction,
00:24:28.563 --> 00:24:31.943
we're going to start here, maybe they'll sue us, maybe they won't,
00:24:32.023 --> 00:24:33.143
and we'll see what happens.
00:24:33.583 --> 00:24:40.003
I kind of wonder if when it happened, I kind of wondered if HRSA was afraid of lawsuits.
00:24:40.203 --> 00:24:43.923
So that's why they just kind of went with the manufacturers.
00:24:44.163 --> 00:24:49.803
Which is really unfair because the health center had an argument that this manufacturer
00:24:49.803 --> 00:24:53.363
audit should have never been permitted, should have never been allowed to move forward.
00:24:53.363 --> 00:24:58.723
But to spend six figures to be right, you don't get anything back on that.
00:24:58.723 --> 00:25:01.563
It isn't there's no there's no award at the end of that case.
00:25:01.763 --> 00:25:05.963
You just get her to change what it did. They're not going to do that.
00:25:06.443 --> 00:25:10.103
The manufacturer might. But the health center is probably not going to invest.
00:25:11.183 --> 00:25:14.363
Even if they do, that six figures would be patient care money.
00:25:14.523 --> 00:25:17.623
Yeah. Yeah. It's not sitting in a litigation pool somewhere. Yeah.
00:25:18.243 --> 00:25:24.183
Yeah. So what other lawsuits potentially could we be seeing in the next few months?
00:25:24.343 --> 00:25:29.863
We've seen some startling patient definition audit reports from HRSA.
00:25:30.083 --> 00:25:35.283
And just to set the table, last November, the Genesis case comes out of a federal
00:25:35.283 --> 00:25:36.343
court in South Carolina.
00:25:36.643 --> 00:25:40.743
A judge is finally looking at the way HRSA applies the patient definition and
00:25:40.743 --> 00:25:46.023
basically says, I'm okay with this 1996 guidance, but these other location timing
00:25:46.023 --> 00:25:48.883
requirements that you've added on, they're not obvious from the statute.
00:25:49.563 --> 00:25:54.403
And the hope is, great, now we get to just focus on, do we have a patient relationship?
00:25:54.603 --> 00:25:57.543
And if we do, we can use 340B, and if we don't, we can't.
00:25:57.663 --> 00:26:02.463
But we knew HRSA may or may not adopt that entire mindset, but they were probably
00:26:02.463 --> 00:26:05.203
going to have to go back and change something about the way they were applying
00:26:05.203 --> 00:26:08.203
location tests and referral tests and things like that.
00:26:08.203 --> 00:26:14.643
So we knew we wouldn't really get audit reports for a while because the decision comes out in November.
00:26:15.003 --> 00:26:18.163
If people make changes, it's going to be in December, January,
00:26:18.383 --> 00:26:20.623
February, then they have to get picked for an audit.
00:26:20.803 --> 00:26:23.343
And then the audit has to look at that window from that window.
00:26:23.343 --> 00:26:29.143
March 4th. So we finally started getting some of those come shake out of HRSA in September.
00:26:29.503 --> 00:26:34.143
And we have at least a couple, we've seen probably four, but at least two that
00:26:34.143 --> 00:26:39.963
we've worked on firsthand where there is a clear hospital or health center encounter
00:26:39.963 --> 00:26:41.683
for a specific condition.
00:26:41.843 --> 00:26:47.623
They are referred to a specific provider for a care exactly following up that
00:26:47.623 --> 00:26:51.163
prior condition, full record sharing, HRSA says no.
00:26:51.603 --> 00:26:55.743
If that's not a valid referral prescription, I don't know what is because that's
00:26:55.743 --> 00:26:58.583
been a valid prescription since day one in the 340B program.
00:26:58.823 --> 00:27:03.123
I guess my question in those scenarios is covered entity type taken into effect,
00:27:03.363 --> 00:27:09.123
into account, because I mean, I think an argument could be made that certain
00:27:09.123 --> 00:27:15.003
covered entity types have more of a long-standing relationship with the patient,
00:27:15.143 --> 00:27:16.823
and some are more episodic in nature.
00:27:16.983 --> 00:27:22.323
I would say for these cases, it does not appear that they took into account covered entity type.
00:27:22.723 --> 00:27:26.943
For example, the hospital case, you have someone with hypertensive emergency,
00:27:27.103 --> 00:27:30.143
high blood pressure emergency. They treat them in the emergency room.
00:27:30.203 --> 00:27:31.343
They get admitted for a week.
00:27:31.703 --> 00:27:35.103
The doctor comes and rounds on them, and then they refer the patient to that
00:27:35.103 --> 00:27:39.103
same doctor at their private practice that shares records back with the hospital.
00:27:39.323 --> 00:27:43.403
It's hard to get a tighter length than that between the entire episode of care.
00:27:44.123 --> 00:27:49.223
And then we had a health center that was also part of this batch that had the
00:27:49.223 --> 00:27:54.003
usual many, many, many encounters with the patient, but this one prescription
00:27:54.003 --> 00:27:56.423
was an outside provider that they disallowed.
00:27:56.883 --> 00:28:02.383
And I think if they don't change those audit reports after, for those of you
00:28:02.383 --> 00:28:05.503
who don't know, you get a 340B audit report, you get to challenge it,
00:28:05.583 --> 00:28:06.543
then you'll get a final report.
00:28:06.763 --> 00:28:09.963
If they don't change it before the final report, some of these entities are
00:28:09.963 --> 00:28:14.783
going to sue, and they're going to basically just cite Genesis as the basis for their suit.
00:28:14.983 --> 00:28:19.183
And even though Genesis had that footnote that it only applied to Genesis.
00:28:19.743 --> 00:28:23.083
That's relatively common for. Yeah, that's normal, isn't it?
00:28:23.323 --> 00:28:24.523
Well, it's the same federal law.
00:28:24.883 --> 00:28:28.983
Yeah, well, the language is the same for everybody, right?
00:28:29.343 --> 00:28:33.043
Like, OK, that opinion might have applied to Genesis, but it interpreted the term patient.
00:28:33.557 --> 00:28:37.097
Which is only mentioned once in the 340B statute. And, you know,
00:28:37.177 --> 00:28:40.937
the plain meaning of the term. Miriam does not change based upon the entity type.
00:28:41.297 --> 00:28:47.397
Miriam is Miriam is Miriam. So I don't know why HRSA, other than seeking to
00:28:47.397 --> 00:28:51.277
get another bite at the apple, just for my pharmacist, I'm going to back up, all right?
00:28:51.437 --> 00:28:55.237
So 340B is a pricing and purchasing statute, you know, significant discounts.
00:28:55.577 --> 00:28:59.897
And the term patient's mentioned once, and that's what sets the limitation on what you can purchase.
00:29:00.217 --> 00:29:02.457
If it's your patient, you can purchase. If it's not your patient,
00:29:02.457 --> 00:29:05.837
We're talking about a physician-patient relationship, a provider-patient relationship, right?
00:29:06.057 --> 00:29:09.697
We're not talking about provider-patient relationship for every healthcare service
00:29:09.697 --> 00:29:11.557
that ever happened to this person everywhere in the world.
00:29:11.757 --> 00:29:14.697
You just have to have a relationship with your patient. Simple.
00:29:14.817 --> 00:29:15.637
Did you render a service?
00:29:15.957 --> 00:29:20.497
Well, HRS has taken it, as Jason mentioned, and applying it across the world in every way.
00:29:20.597 --> 00:29:24.417
You have to be responsible for everything that ever happens to this patient
00:29:24.417 --> 00:29:25.917
in order to purchase Dr. 340B.
00:29:26.077 --> 00:29:29.837
And that's just not what the term patient means. It doesn't mean,
00:29:29.997 --> 00:29:32.777
you know, everything that ever happens, you have to be responsible for.
00:29:32.857 --> 00:29:37.697
And I would recommend if you're working in this program that everyone go out and read Genesis.
00:29:38.117 --> 00:29:42.517
Even as a non-lawyer, it's really easy to understand. It was written in a way
00:29:42.517 --> 00:29:43.977
that's very approachable.
00:29:44.177 --> 00:29:48.217
Yeah. And it's 33 pages. There are not dense legal concepts in that.
00:29:48.437 --> 00:29:51.257
I didn't have to Google words like I would have had to today. Exactly.
00:29:51.557 --> 00:29:54.137
Because it really all turns on what does the word patient mean?
00:29:54.217 --> 00:29:57.897
Yeah. What did Congress mean when they used it, you know, 30 years ago?
00:29:58.117 --> 00:30:01.577
Yeah. Well, I have a question. So if you go to your doctor, here's a simple question.
00:30:01.877 --> 00:30:05.457
You got to make this fast, man. We are running out of time here. Well, simple.
00:30:05.557 --> 00:30:08.437
When you go to your primary care doctor and then you've been going to your doctor
00:30:08.437 --> 00:30:11.377
and then you go to another doctor, you decide to get a second opinion.
00:30:11.537 --> 00:30:13.797
Does that mean that primary care doctor is no longer your doctor?
00:30:14.590 --> 00:30:18.070
No, she doesn't say no. She's a patient. Pretty obvious.
00:30:18.350 --> 00:30:21.290
But I think the problem is, because this was congressional intent,
00:30:21.530 --> 00:30:25.350
companies are purchasing a lot of drugs and a person wants to reel that back.
00:30:25.670 --> 00:30:27.330
She doesn't have the authority to do that.
00:30:27.710 --> 00:30:30.990
All right. So knowing that we are running tight on time, I'm going to say final
00:30:30.990 --> 00:30:35.870
thoughts on litigation. It could be existing or what we anticipate seeing.
00:30:36.190 --> 00:30:40.110
I mean, from my side, I would say we're going to see a lot more litigation.
00:30:40.230 --> 00:30:44.090
We're going to see some litigation flow through the administrative dispute resolution
00:30:44.090 --> 00:30:47.770
process and be it brought through HRSA and then to federal court.
00:30:48.010 --> 00:30:54.990
And then we will have to see how a new administration will change policy within
00:30:54.990 --> 00:30:57.090
HHS or within HRSA if they do.
00:30:57.270 --> 00:31:00.170
There may not be much change between one administration to the next,
00:31:00.190 --> 00:31:02.110
or there could be significant change.
00:31:02.310 --> 00:31:05.710
But things like the rebate model and other things, we have to see what happens.
00:31:06.110 --> 00:31:08.650
Yeah, I definitely think we're going to see litigation. I think we're going
00:31:08.650 --> 00:31:11.250
to get a lot of administrative dispute resolution. We're going to get a lot
00:31:11.250 --> 00:31:13.730
of manufacturer audits of covered entities.
00:31:14.110 --> 00:31:17.450
So covered entities, hunker down, get your legal counsel.
00:31:17.910 --> 00:31:22.750
The drug makers will be auditing you. But I do think that all the courts agree
00:31:22.750 --> 00:31:27.410
the plain language dictionary definition of terms in a statute is what prevails.
00:31:27.630 --> 00:31:30.950
So we're getting attacked by the government overbroad.
00:31:31.310 --> 00:31:34.570
We're getting attacked by the drug makers trying to insert language into the
00:31:34.570 --> 00:31:36.830
statute where they want to limit 340B purchases.
00:31:37.370 --> 00:31:41.090
A lot of allegation, but I'm confident that the Covenant needs will defend themselves properly.
00:31:41.350 --> 00:31:46.550
I think it's been a great conversation, and I think we're going to see a lot
00:31:46.550 --> 00:31:52.410
more coming down the road as we're especially changing executive administrations.
00:31:52.730 --> 00:31:56.870
And as you said, Jason, so all of this could change tomorrow.
00:31:57.130 --> 00:32:02.490
So it is a point in time, but it's good from a pharmacist's perspective to hear
00:32:02.490 --> 00:32:08.190
an easy explanation of some of these things that are not in our daily vocabulary.
"I would recommend for anyone working in this program, that you go out and read Genesis. Even as a non-lawyer, it's really easy to understand."
Meet Logan Yoho, PharmD, BCACP, 340B ACE, and co-host of the 340Banter Podcast. With nearly a decade of experience in the 340B industry, Logan is dedicated to helping health centers optimize and maintain successful, compliant 340B Programs. As Director of Advocacy and Education at FQHC 340B Compliance, he focuses on implementing entity-owned pharmacies and guiding advocacy efforts for 340B. Logan’s extensive background includes leading the pharmacy and 340B programs at Hopewell Health Centers, serving as Apexus 340B University Faculty, and chairing the Ohio 340B FQHC Consortium. Logan’s leadership and expertise have earned him multiple awards, and he brings a wealth of knowledge to every episode of 340Banter.
Meet Chelsea Violette, PharmD, BCACP, 340B ACE, and your co-host for the 340Banter Podcast. With over a decade of experience in pharmacy and 340B Program management, Chelsea brings a wealth of knowledge to the table. As Chief Operating Officer at FQHC 340B Compliance, she works tirelessly to support health centers across the country, ensuring they have the tools and strategies they need to succeed. Chelsea’s hands-on experience as a 340B Consultant and Pharmacy Manager, combined with her expertise as a subject matter expert for the Apexus 340B Prime Vendor Program, makes her a trusted voice in the world of 340B compliance. Tune in for her practical insights, guidance, and lively discussions on all things 340B.
00:00:00.017 --> 00:00:05.237
Welcome to the 340 Banter podcast. Today, we're joined by Mark Ogunshusi,
00:00:05.537 --> 00:00:07.697
as well as Jason Reddish from Powers Law.
00:00:08.097 --> 00:00:12.577
We'll be discussing recent legal arguments pharmaceutical manufacturers have
00:00:12.577 --> 00:00:17.677
been using inside the courts, as well as what we see coming down the road in litigation.
00:00:18.357 --> 00:00:22.857
Even though Mark and Jason are lawyers, you should not use this as legal advice
00:00:22.857 --> 00:00:24.617
and should consult general counsel.
00:00:45.157 --> 00:00:49.737
All right. So 340B has been really rampant in the courtrooms lately,
00:00:49.917 --> 00:00:51.737
both at the state and the federal level.
00:00:51.857 --> 00:00:55.237
So I was wondering if we could kind of go through today and get your insights
00:00:55.237 --> 00:00:59.617
from the legal perspective, both of us being pharmacists, and maybe go through
00:00:59.617 --> 00:01:02.937
some of the arguments that have come up in those court cases lately.
00:01:03.617 --> 00:01:06.137
Yeah, I mean, that sounds like a good idea, but we're going to keep it,
00:01:06.157 --> 00:01:08.077
you know, related to pharmacists.
00:01:08.417 --> 00:01:11.657
We're not talking to lawyers, we're talking to pharmacists. It was a lot easier
00:01:11.657 --> 00:01:15.697
when there were only like two 340B cases for the first 30 years to keep track of.
00:01:16.037 --> 00:01:19.097
Oh, yeah. Well, we talked about, you know, going through case by case,
00:01:19.157 --> 00:01:21.317
but we would be here for weeks. So we're going to go back.
00:01:21.557 --> 00:01:23.917
And we would need a lot of paper in front of us, which would not be helpful.
00:01:23.917 --> 00:01:25.237
We'll go by arguments instead at this point.
00:01:25.997 --> 00:01:30.097
So let's kick us off. I think preemption is one of the first ones that had come up.
00:01:30.257 --> 00:01:34.077
You want to talk us kind of through what that is and how that's played out in the court cases so far.
00:01:34.157 --> 00:01:38.137
Yeah. So my pharmacists out there, we're dealing with these state laws that
00:01:38.137 --> 00:01:40.757
require drugs to be shipped to your pharmacies.
00:01:41.677 --> 00:01:46.897
And, you know, the drug makers, manufacturers don't like these state laws because
00:01:46.897 --> 00:01:52.197
they require that these discounted medications that safety net providers provide
00:01:52.197 --> 00:01:53.537
are shipped to your pharmacies.
00:01:53.617 --> 00:01:58.437
And they're saying, no, federal law is the absolute, because 340 is a federal
00:01:58.437 --> 00:02:01.177
pricing statute, right? That's where the price occurs.
00:02:01.437 --> 00:02:04.457
Say it's absolute, leaves no room for state law. So therefore,
00:02:04.737 --> 00:02:06.077
it preempts the state law.
00:02:06.297 --> 00:02:09.577
So any state law relating to delivery, and we all know there's all sorts of
00:02:09.577 --> 00:02:13.377
state laws relating to delivery, wholesaler laws and things of that nature,
00:02:13.517 --> 00:02:15.397
controlled substance laws related to distribution.
00:02:16.585 --> 00:02:21.905
Somehow, spontaneously, a federal pricing statute allegedly preempts or supplants
00:02:21.905 --> 00:02:27.025
or should take the place of or cancels out the state law. And that's preemption.
00:02:27.465 --> 00:02:30.305
So that's the argument. I don't know if you wanted to get into the disposition
00:02:30.305 --> 00:02:35.245
of these cases. So I think we've seen a lot of success at the state level.
00:02:35.485 --> 00:02:39.545
And so obviously that argument is not working.
00:02:39.765 --> 00:02:45.645
Is that what we're seeing? Yeah, at the federal court level,
00:02:45.785 --> 00:02:51.465
but looking at state laws, they've found that the 340B statute doesn't address delivery.
00:02:51.825 --> 00:02:57.345
It addresses pricing and addresses some other aspects of acquiring the drugs,
00:02:57.365 --> 00:03:01.125
but it doesn't speak to whether drugs have to be shipped to a certain place
00:03:01.125 --> 00:03:06.185
or whether manufacturers have to ship to where the covered entity wants them to be shipped.
00:03:06.745 --> 00:03:10.205
So the preemption arguments have largely fallen flat.
00:03:10.725 --> 00:03:14.985
They were also hurt a little bit because on the cases that challenged whether
00:03:14.985 --> 00:03:19.225
manufacturers could impose restrictions on contract pharmacy restrictions,
00:03:19.405 --> 00:03:22.685
their whole argument is, well, there's a huge gap in the statute. It just says offer.
00:03:22.865 --> 00:03:25.905
So we can fill that gap. If there's a huge gap in the statute,
00:03:26.105 --> 00:03:28.985
it obviously doesn't occupy all of the 340B field.
00:03:29.125 --> 00:03:33.605
And there was room for state regulation in areas that states typically regulate shipments.
00:03:33.985 --> 00:03:36.545
I want to add to what Jason's name is. we're talking to pharmacists, right?
00:03:36.985 --> 00:03:40.565
I mean, how complex is the practice of pharmacy? How many variations do we see?
00:03:40.905 --> 00:03:45.245
We see institutional pharmacy at hospitals. We see retail pharmacies.
00:03:45.365 --> 00:03:48.225
We see long-term care pharmacies. We see infusion pharmacies.
00:03:48.785 --> 00:03:52.345
And state laws govern the practice of pharmacy. In fact, Jason,
00:03:52.865 --> 00:03:54.965
does the 340 statute even mention the term pharmacy?
00:03:55.165 --> 00:03:57.225
No, the word pharmacy is not used anywhere. Not once.
00:03:57.565 --> 00:04:00.165
So why are the drug makers saying that the federal law preempts the state law?
00:04:00.285 --> 00:04:04.225
I don't know. I don't know. All right. Well, then we'll move on from preemption.
00:04:05.025 --> 00:04:09.865
Next one we've seen is the Dormant Commerce Clause. I mean, that's a mouthful.
00:04:10.045 --> 00:04:12.165
The Dormant Commerce Clause.
00:04:12.405 --> 00:04:16.565
Long story short, for my pharmacists out there, they believe these state delivery
00:04:16.565 --> 00:04:21.865
laws regulate Honda transactions occurring completely out of the state.
00:04:22.025 --> 00:04:26.905
It's an old constitutional law concept that interstate commerce,
00:04:26.905 --> 00:04:28.585
the federal government can regulate.
00:04:28.785 --> 00:04:33.645
And they're saying that a state law that requires the drug maker to not block
00:04:33.645 --> 00:04:37.545
or limit delivery of these discounted drugs to the pharmacies,
00:04:37.725 --> 00:04:41.085
to your pharmacy, regulates out-of-state conduct.
00:04:41.425 --> 00:04:47.125
You know, the drug makers just spontaneously, after years of delivering drugs into states,
00:04:47.705 --> 00:04:52.405
now states can't regulate these deliveries because some drug makers are located
00:04:52.405 --> 00:04:55.245
in that state, some drug makers are located in that state, but at the end of
00:04:55.245 --> 00:04:57.605
the day, they know their drugs are getting to your state.
00:04:57.985 --> 00:05:02.525
And again, that's another argument that I think is a bit spurious, spurious, spurious,
00:05:03.073 --> 00:05:07.373
You know, I haven't seen a new word for me. Well, it's unreasonable.
00:05:10.693 --> 00:05:15.973
It's well, it's unreasonable. I mean, it's like these are old constitutional
00:05:15.973 --> 00:05:18.493
contentions that have never gone anywhere.
00:05:18.713 --> 00:05:23.793
And there's plenty of case law establishing that states can regulate delivery
00:05:23.793 --> 00:05:25.273
of drugs within their borders. Yeah.
00:05:25.413 --> 00:05:30.073
And so, you know, what we've seen is failure by the drug makers on that.
00:05:30.153 --> 00:05:32.693
In fact, they're dropping those claims, that claim. They're not really even
00:05:32.693 --> 00:05:33.933
included in their litigation.
00:05:34.313 --> 00:05:38.753
And there are plenty of state laws that have impacts on activities outside of the state.
00:05:38.873 --> 00:05:42.513
I mean, one thing I use, I think of often when you're talking about this,
00:05:42.693 --> 00:05:46.033
it's called the Dormant Commerce Clause because the idea is if the federal government
00:05:46.033 --> 00:05:49.353
can regulate commerce between the states, then states can't do anything that
00:05:49.353 --> 00:05:51.013
hinders commerce between states.
00:05:51.093 --> 00:05:53.613
Yeah, that makes sense. But you think about, we watched game shows growing up.
00:05:53.693 --> 00:05:55.693
You've got the California emission standards.
00:05:55.913 --> 00:05:58.453
Like every car was up to the California emission standards.
00:05:58.853 --> 00:06:02.193
They're the biggest market. If they set an emission standard and they're allowed
00:06:02.193 --> 00:06:05.553
to under state law, that's going to affect everybody out of state because they're
00:06:05.553 --> 00:06:08.453
probably going to go down to that standard to be able to ship drugs to,
00:06:08.633 --> 00:06:09.933
I mean, ship cars to California.
00:06:10.553 --> 00:06:14.633
So it's not unusual for a state to have a minimum standard for their own state
00:06:14.633 --> 00:06:17.453
that is going to affect people who want to ship into the state.
00:06:17.453 --> 00:06:21.293
As long as it applies equally to a drug manufacturer in Arkansas as it does
00:06:21.293 --> 00:06:23.733
to one in New York, then there's not really an impact. Yeah,
00:06:23.893 --> 00:06:24.913
that's a great explanation.
00:06:26.218 --> 00:06:29.158
All right. So the next one we've got is due process takings.
00:06:29.358 --> 00:06:34.718
So this is what they're really kind of focusing on lately, which is that,
00:06:34.838 --> 00:06:35.718
you know, the government,
00:06:36.058 --> 00:06:41.238
state or federal government can't take private property from private individuals
00:06:41.238 --> 00:06:43.438
or entities without just compensation.
00:06:43.918 --> 00:06:47.858
And so I mentioned we have this is all about the 340B federal pricing statute.
00:06:47.858 --> 00:06:49.598
That's nothing about delivery or distribution.
00:06:50.118 --> 00:06:55.078
But they're alleging that because the statute sets a price that these coverings
00:06:55.078 --> 00:06:58.658
can pay and the state law says you must deliver it to where the coverings say
00:06:58.658 --> 00:07:01.518
you should deliver it, that that's taking their property.
00:07:01.638 --> 00:07:04.958
They have patents and they should be able to set their prices unreasonably high.
00:07:05.078 --> 00:07:09.058
I'm not going to get crazy, but we know drug makers are 300 to 1,000 percent
00:07:09.058 --> 00:07:11.158
in the United States and the other developed country in the world.
00:07:11.158 --> 00:07:15.458
We know we're being screwed here in the United States, but they're saying that
00:07:15.458 --> 00:07:17.958
that's a taking and that they weren't justly compensated.
00:07:18.598 --> 00:07:21.918
But, you know, the counterargument to that, similar to with the inflation reduction
00:07:21.918 --> 00:07:24.438
for my pharmacist, Medicare negotiated prices,
00:07:25.038 --> 00:07:30.478
discounted Medicare drugs, is that the drug makers voluntarily participate in
00:07:30.478 --> 00:07:34.098
the 340B program so that their drugs are covered under Medicare and Medicaid.
00:07:34.298 --> 00:07:37.658
The business decision at the end of the day. Well, it's a really good business decision.
00:07:38.258 --> 00:07:41.978
How much taxpayer, I mean, how much money do you think these companies are making
00:07:41.978 --> 00:07:45.838
off of Medicare and Medicaid in exchange for giving some safety net providers
00:07:45.838 --> 00:07:48.298
critical discounts to keep our country moving?
00:07:48.738 --> 00:07:54.138
Billions and billions of dollars. Have we seen that actually go through any
00:07:54.138 --> 00:07:58.358
court cases yet? Has it been successful? Actually, on the Inflation Reduction
00:07:58.358 --> 00:08:00.718
Act side, it's been rejected repeatedly.
00:08:00.918 --> 00:08:04.098
The taking cost. And it actually makes a lot more sense on that side,
00:08:04.238 --> 00:08:08.298
where they say, I've got this patent window, and now you're telling me that
00:08:08.298 --> 00:08:13.178
I have to submit to your price, basically, or pay an incredibly high tax.
00:08:14.218 --> 00:08:16.938
And if I don't, my only other option is drop out of Medicare.
00:08:17.398 --> 00:08:19.918
And so they're saying we're being hijacked to do it.
00:08:19.998 --> 00:08:23.838
And the counter argument is Medicare is the biggest drug market in the world.
00:08:24.098 --> 00:08:27.338
It's one of the best payers in the world. If you want access to that market,
00:08:27.498 --> 00:08:28.958
you have to play by that market's rules.
00:08:29.478 --> 00:08:34.298
And for the most part, that is that is largely succeeded and knocked down the
00:08:34.298 --> 00:08:35.278
manufacturer arguments.
00:08:35.578 --> 00:08:40.138
You know, whether the IRA survives a change in in the House or presidency is
00:08:40.138 --> 00:08:44.198
probably a bigger conversation or whether it survives with changes is probably a bigger conversation.
00:08:44.218 --> 00:08:48.178
But the due process arguments have not gotten them over the finish line.
00:08:48.478 --> 00:08:51.218
You can't take what you're voluntarily participating in.
00:08:51.558 --> 00:08:54.938
Yeah, there's an option that the manufacturers could choose to not be part of
00:08:54.938 --> 00:08:58.498
the pharmacy pricing agreement, which would remove them from Medicaid and Medicare,
00:08:58.738 --> 00:09:03.638
but would also remove them from the 340B program. PBM contracts are terrible.
00:09:03.858 --> 00:09:07.698
You could choose not to contract with the major PBMs. You won't be able to run
00:09:07.698 --> 00:09:09.278
a pharmacy, but you could choose that.
00:09:09.578 --> 00:09:13.698
Well, yeah, of course. I think one thing to add on to the PBM situation,
00:09:13.698 --> 00:09:17.518
if I'm a pharmacy, is that I'm not, by signing this PBM contract,
00:09:17.658 --> 00:09:20.658
making billions and billions of taxpayer dollars.
00:09:20.978 --> 00:09:25.038
I mean, these drug companies are making massive amounts by, you know,
00:09:25.178 --> 00:09:28.858
participating in the 340B program because their drugs are covered under a separate
00:09:28.858 --> 00:09:32.598
program, Medicare, Medicaid, and other programs. I mean, they're killing it.
00:09:32.698 --> 00:09:35.778
I mean, I mean, anyways, I'm not going to get into it. They make a lot of money.
00:09:35.858 --> 00:09:36.698
Let's just put it that way.
00:09:37.438 --> 00:09:40.338
Really? I didn't get that message. They're doing okay. Stop punching down.
00:09:40.658 --> 00:09:44.958
Okay. All right. So we'll move on to the contracts clause. The next one we're seeing.
00:09:45.478 --> 00:09:48.918
Yeah, this one's pretty simple. The drug makers are saying, you know,
00:09:49.058 --> 00:09:52.078
by requiring us to deliver drugs to where the patients can actually pick them
00:09:52.078 --> 00:09:57.058
up, you're modifying our contracts with, let's say, wholesalers or other contracts that they have.
00:09:57.358 --> 00:10:02.978
And, you know, again, none of these claims have won in any federal court. You know, they're.
00:10:03.533 --> 00:10:09.653
Untenable propositions that, you know, really would upset decades-long practice.
00:10:09.953 --> 00:10:11.433
You know, there's plenty of regulations
00:10:11.433 --> 00:10:13.833
on it. Let's talk about state-controlled substance laws, right?
00:10:14.073 --> 00:10:18.313
That modifies a wholesaler contract. You know, there's plenty of state laws
00:10:18.313 --> 00:10:21.113
that have impacts on your contracts.
00:10:21.233 --> 00:10:25.473
The bottom line is states are free to protect public health and safety within their borders.
00:10:25.793 --> 00:10:31.073
And, you know, I hope the drug makers get with the public health program and
00:10:31.073 --> 00:10:32.833
stop these spurious arguments.
00:10:33.473 --> 00:10:36.533
Yeah, I mean, contracts clause is a tough thing to argue. Basically,
00:10:36.613 --> 00:10:40.653
there's a line in the Constitution that says no state shall impair the obligation of contracts.
00:10:40.973 --> 00:10:45.393
But that could be like, I'm going to pass a law that says Logan Yoho doesn't
00:10:45.393 --> 00:10:49.133
owe his mortgage to that bank in Ohio anymore. You're lucky that. Yeah.
00:10:51.033 --> 00:10:55.753
It's not, there are a lot of exceptions in balancing tests when you're imposing
00:10:55.753 --> 00:11:00.673
regulations that help health and safety that happen to have an impact on existing contracts.
00:11:00.933 --> 00:11:04.593
So one of the things I like about talking through these arguments and explaining
00:11:04.593 --> 00:11:10.053
them to somebody that's not a lawyer is that what we're seeing is that in some
00:11:10.053 --> 00:11:13.133
states they're considering this, but there's fears of this litigation.
00:11:13.133 --> 00:11:18.673
So it's really good that we're discussing this and showing that these arguments
00:11:18.673 --> 00:11:19.593
haven't been successful.
00:11:19.813 --> 00:11:23.533
I think there's value there. And we went from Louisiana, I mean,
00:11:23.553 --> 00:11:28.953
Arkansas to Arkansas and Louisiana to Arkansas, Louisiana, Maryland,
00:11:29.053 --> 00:11:34.133
Mississippi, Missouri, Minnesota, Kansas, West Virginia in like three and a half, four years.
00:11:34.293 --> 00:11:38.433
And there were probably another five or six states that there was fear.
00:11:38.633 --> 00:11:41.873
Well, we don't want to get sued or we're afraid that we'll get pulled into this litigation.
00:11:42.213 --> 00:11:47.333
Every time one of these states wins, it makes it easier and easier to pass a law in another state.
00:11:47.513 --> 00:11:50.933
So maybe we go from eight now to 15 next year. Yeah.
00:11:51.493 --> 00:11:55.053
Especially if there's fear about what's going to happen at the federal level.
00:11:55.213 --> 00:11:59.013
Yeah, I think that could play in as a positive at the state level.
00:11:59.133 --> 00:12:01.653
Yeah, when you read the opinions, the judges aren't even...
00:12:02.498 --> 00:12:05.278
I mean, they're duly considering the drug maker's arguments,
00:12:05.278 --> 00:12:09.098
but they're, you know, they're slapping them down back and forth.
00:12:09.338 --> 00:12:13.418
So really, we're just talking about multinational, highly profitable companies
00:12:13.418 --> 00:12:14.638
that have the money to sue,
00:12:14.918 --> 00:12:18.518
to slow down enforcement against them so that they continue to drive up shareholder
00:12:18.518 --> 00:12:21.598
value and make more money, money, money, money on the backs of our community
00:12:21.598 --> 00:12:24.278
pharmacies, on the backs of our patients who are in underserved communities,
00:12:24.458 --> 00:12:28.898
on the backs of our safety net providers and public health providers throughout the country. Yeah.
00:12:29.178 --> 00:12:32.238
I'm going to take us to an argument that's not a constitutional argument,
00:12:32.358 --> 00:12:37.738
but one we're seeing come up, I think, a lot more recently is the kind of questioning
00:12:37.738 --> 00:12:40.158
the replenishment system and maintaining the title of the drug.
00:12:40.758 --> 00:12:44.418
Yeah, so that fits within a constitutional argument. It fits within,
00:12:44.578 --> 00:12:48.238
you know, AstraZeneca is alleging that in Arkansas, for example.
00:12:48.498 --> 00:12:52.658
But it fits within the due process takings, like taking property without just
00:12:52.658 --> 00:12:54.098
compensation, like patented property.
00:12:54.358 --> 00:12:57.838
And it fits within the preemption. They're saying that the 340 statute says
00:12:57.838 --> 00:13:01.698
a covered entity, the safety net provider who's entitled to purchase the drug,
00:13:01.858 --> 00:13:06.098
shall not transfer the drug to anyone other than a person, a patient,
00:13:06.258 --> 00:13:07.398
a patient of the covered entity.
00:13:07.558 --> 00:13:09.818
Yes. Right. Which has been around since the beginning of time.
00:13:10.158 --> 00:13:14.318
So the drug makers are saying replenishment, you know, where the drug is dispensed,
00:13:14.598 --> 00:13:19.098
a drug is dispensed, and a drug replenishes the drug, that's all I'm going to say about it,
00:13:19.458 --> 00:13:22.938
violates the transfer prohibition, and it's a taking of their property,
00:13:23.038 --> 00:13:25.438
their discounted drugs. Now, let's just think about it.
00:13:26.642 --> 00:13:29.502
Replenishment it's just an inventory accounting system first in
00:13:29.502 --> 00:13:32.362
first out yada yada has been around since before
00:13:32.362 --> 00:13:35.662
establishment of the united states it's well established
00:13:35.662 --> 00:13:38.642
that when a party is
00:13:38.642 --> 00:13:44.182
has some inventory especially fungible goods you know you don't have to account
00:13:44.182 --> 00:13:48.522
with detailed particularity one product versus another product they're fungible
00:13:48.522 --> 00:13:51.602
they're inter place they're interchangeable for example when i put money into
00:13:51.602 --> 00:13:55.642
the bank and the bank mixes that money up with all the other money in the bank.
00:13:55.782 --> 00:13:57.862
That doesn't mean the bank automatically owns your money.
00:13:58.302 --> 00:14:01.442
The bank is just holding that money on your behalf. You're also not getting
00:14:01.442 --> 00:14:04.162
the exact same, you know, dollar bill back.
00:14:04.622 --> 00:14:07.442
Yeah, you're not getting the serial number. Yeah. Well, yeah.
00:14:07.602 --> 00:14:09.822
And look, I'm not going to get into the legal arguments, but at the end of the
00:14:09.822 --> 00:14:14.902
day, and Jason probably wants to talk more about this, after decades-long practice,
00:14:15.022 --> 00:14:17.342
replenishment systems were used before 340B was enacted.
00:14:17.642 --> 00:14:22.942
Under Nonprofit Institution Act, for example, for, you know, own-use hospitals.
00:14:23.542 --> 00:14:28.082
You know, the thing is, is that after 30 years of practice or more,
00:14:28.342 --> 00:14:32.142
these drug companies are now all of a sudden saying, you know,
00:14:32.262 --> 00:14:34.642
we've been dealing with this, this has been going on.
00:14:34.942 --> 00:14:38.622
It's even more accurate than physically separating the product because you trace
00:14:38.622 --> 00:14:40.622
each drug on an 11-digit.
00:14:40.722 --> 00:14:44.122
Every pill that goes out, you make sure that went to a patient, right?
00:14:44.362 --> 00:14:47.982
They're saying that now it's illegal. Just so you can understand how we feel
00:14:47.982 --> 00:14:51.142
in the covered in the community after 30 years, all of a sudden,
00:14:51.222 --> 00:14:53.642
oh, no, that's illegal. No, you guys are taking my property.
00:14:54.282 --> 00:14:58.922
And actually, it's a good segue into everything that manufacturers are looking
00:14:58.922 --> 00:15:00.902
at that maybe they haven't challenged before.
00:15:01.182 --> 00:15:05.362
A lot of people don't know that pharma filed suit against HRSA in 1996 when
00:15:05.362 --> 00:15:08.782
the first contract pharmacy guidance came out and they actually pulled it back
00:15:08.782 --> 00:15:10.782
because of pushback from Ryan White Clinics.
00:15:11.500 --> 00:15:16.340
So, you know, they were they had an opportunity when this was announced in 1996
00:15:16.340 --> 00:15:20.660
to litigate it and fight over whether the program allowed contract pharmacies.
00:15:20.860 --> 00:15:26.000
They didn't. Now they come back literally 24 years later and they start self-imposing
00:15:26.000 --> 00:15:27.500
some restrictions on the program.
00:15:27.700 --> 00:15:33.260
Does that impact their, I don't know, have a leg to stand on when you're making
00:15:33.260 --> 00:15:36.440
that argument when you've not challenged it for 25 years?
00:15:36.440 --> 00:15:40.420
There is a legal concept. It's called latches, which literally means you delayed
00:15:40.420 --> 00:15:43.900
so long that it's unfair to the person that you're trying to enforce it against.
00:15:44.100 --> 00:15:47.880
It doesn't apply as often when you're dealing with challenging a government
00:15:47.880 --> 00:15:49.800
aspect, but it is a factor.
00:15:49.980 --> 00:15:53.220
I mean, that you voluntarily participated in this model.
00:15:53.480 --> 00:15:58.880
You knew who you were shipping the drugs to for 20 years and you didn't balk at it then.
00:15:59.500 --> 00:16:02.680
But manufacturers are trying to challenge the replenishment model.
00:16:02.680 --> 00:16:07.440
If you think about risk-reward for them, if they were somehow able to get rid
00:16:07.440 --> 00:16:11.140
of replenishment, you would cut the contract pharmacy market in half.
00:16:11.320 --> 00:16:13.700
You would have problems with hospitals and split billing.
00:16:13.980 --> 00:16:17.820
Yeah, hospitals wouldn't be able to manage their clinic-administered or physician-administered
00:16:17.820 --> 00:16:20.460
drugs. They would have to severely limit where they can use 340B.
00:16:20.580 --> 00:16:23.160
And a lot of health centers, even their entity-owned pharmacies,
00:16:23.160 --> 00:16:26.640
are virtual in nature. Depending on Medicaid carve-out and things like that,
00:16:26.700 --> 00:16:29.900
you may have single neutral inventory there.
00:16:30.100 --> 00:16:36.320
Yeah. So you're talking about maybe cutting the volume of 340B purchasing nationwide by $30 billion.
00:16:36.940 --> 00:16:41.660
And they're going to spend some money to try that. And it's not for the purpose. Let's just be clear.
00:16:42.100 --> 00:16:47.040
It's not for the purpose of greater, you know, we don't want this because it'll
00:16:47.040 --> 00:16:51.300
be more accurate if you maintain a separate inventory. Because the second you
00:16:51.300 --> 00:16:55.080
dispense a drug out of a physically separate inventory to a non-patient,
00:16:55.300 --> 00:16:56.700
that's diversion, right?
00:16:56.820 --> 00:17:01.500
There's no opportunity to true up. There's no opportunity to account for the
00:17:01.500 --> 00:17:03.440
pills that are fungible, that are mixable.
00:17:03.800 --> 00:17:07.420
So it really is just an opportunity to do what Jason is saying,
00:17:07.980 --> 00:17:08.780
challenging replenishment.
00:17:09.000 --> 00:17:14.140
It's just to save money. It's just to make money. It's just a multinational profit.
00:17:14.440 --> 00:17:18.060
Or to make things more complicated to the point that you can no longer comply.
00:17:18.300 --> 00:17:24.240
And therefore, you can charge your extremely 300 to 1,000% high list price drugs. Yeah. Anyways.
00:17:24.620 --> 00:17:27.740
All right. Right. So I've got one more constitutional argument for us to hit
00:17:27.740 --> 00:17:32.860
on that's been seen in some of the cases we've seen so far, but seems to be less frequent now.
00:17:33.700 --> 00:17:37.320
Unconstitutional vagueness, which sounds to me just pretty, pretty vague.
00:17:37.520 --> 00:17:40.760
Like it seems like it's pretty self-explanatory. story yeah yeah
00:17:40.760 --> 00:17:43.420
the bottom line is if you're going to
00:17:43.420 --> 00:17:46.340
punish somebody for violating a law they have to know what they're
00:17:46.340 --> 00:17:50.820
prohibited from doing so you know if you have a law in the books that says anybody
00:17:50.820 --> 00:17:56.060
who is is performing vagrancy will be charged with a misdemeanor and you ask
00:17:56.060 --> 00:17:59.200
somebody what is vagrancy and they come up with whatever decision they whatever
00:17:59.200 --> 00:18:02.320
definition they want that's going to be unconstitutionally vague can't create
00:18:02.320 --> 00:18:03.740
a criminal record for someone because.
00:18:06.126 --> 00:18:11.826
Manufacturers have tried to argue that some of the language in these state statutes
00:18:11.826 --> 00:18:14.246
is unconstitutionally vague.
00:18:14.466 --> 00:18:17.426
And I think they've been shut out. I know they've been shut out on those.
00:18:17.546 --> 00:18:20.046
And I think they've stopped really raising that argument.
00:18:20.386 --> 00:18:23.626
Yeah, I think they've stopped raising the argument. If you want an opinion,
00:18:23.766 --> 00:18:28.806
you can look at the Louisiana lawsuits, plural with Pharma and AstraZeneca,
00:18:29.166 --> 00:18:32.486
that they lost with flying colors because the law is pretty clear.
00:18:33.026 --> 00:18:36.426
But unconstitutional vagueness, I mean, a law that says you must not limit delivery
00:18:36.426 --> 00:18:38.046
of a product is pretty concrete.
00:18:38.226 --> 00:18:41.966
I mean, what they want you to do, what they want to do is obfuscate very clear
00:18:41.966 --> 00:18:47.326
laws such that they can create grounds to invalidate them and make more money.
00:18:47.486 --> 00:18:49.506
But at the end of the day, don't limit delivery.
00:18:49.706 --> 00:18:54.406
Your policy specifically references distribution and limiting distribution and
00:18:54.406 --> 00:18:55.426
or prohibiting distribution.
00:18:55.926 --> 00:19:00.066
And that's pretty concrete. And that's why the unconstitutional vagueness argument
00:19:00.066 --> 00:19:03.626
has not, you know, it doesn't have legs. It hasn't had any legs.
00:19:03.926 --> 00:19:08.226
Courts basically have said, you know, under basic case law, we can read the
00:19:08.226 --> 00:19:10.646
statute in a way that's concrete. Right.
00:19:10.846 --> 00:19:13.766
I mean, if you're writing statutes for a state, if you're helping work on a
00:19:13.766 --> 00:19:16.286
bill for your state, you can have it in the back of your mind.
00:19:16.306 --> 00:19:20.406
But the Legislative Council, one of their jobs when they prepare a bill for
00:19:20.406 --> 00:19:23.766
the state is to look for constitutional issues. And that's always going to be
00:19:23.766 --> 00:19:24.606
something they look for.
00:19:24.806 --> 00:19:28.506
So it's already gone through a layer before it gets passed of somebody deciding
00:19:28.506 --> 00:19:30.066
it's not vague. All right.
00:19:30.226 --> 00:19:33.906
So now I kind of want to pivot. And we've talked about the arguments that we've
00:19:33.906 --> 00:19:38.566
seen that are going on in the courtroom right now or have been and say,
00:19:38.726 --> 00:19:41.006
looking forward, what what can we expect?
00:19:41.146 --> 00:19:43.866
Are we going to see some, you know, a lot of the same arguments,
00:19:44.026 --> 00:19:48.206
a lot of the same issues? Are we going to see some new issues coming up? I think new issues.
00:19:48.466 --> 00:19:52.366
So two things that we've been dealing with, and really one of them is now a
00:19:52.366 --> 00:19:57.346
year old, is manufacturers, at least one manufacturer, seeking and obtaining
00:19:57.346 --> 00:20:03.106
permission from HRSA to audit a health center for Medicaid managed care duplicate discounts. Yeah.
00:20:05.559 --> 00:20:09.999
More than a decade, Hearst has said, we don't have any jurisdiction over managed care.
00:20:10.319 --> 00:20:12.759
We're not going to issue. At one point, they said, we're going to issue policy
00:20:12.759 --> 00:20:15.959
in conjunction with CMS on managed care. Then they came back and said, no, we're not.
00:20:16.339 --> 00:20:20.059
Just kidding. Yeah. And the statute itself is written in a way that treats fee-for-service
00:20:20.059 --> 00:20:21.219
differently than managed care.
00:20:21.539 --> 00:20:25.659
When they expanded the rebate program to include managed care in 2010,
00:20:25.979 --> 00:20:29.579
they included a provision that said if the drug's purchased on a 340B account
00:20:29.579 --> 00:20:32.899
and billed to a managed care plan, it's not eligible for a rebate.
00:20:33.099 --> 00:20:37.019
We're only prohibited from billing Medicaid for drugs that are eligible for a rebate.
00:20:37.279 --> 00:20:40.159
So they kind of took it all away from 340B and HRSA.
00:20:40.559 --> 00:20:43.579
It was a big shock. We fought pretty hard.
00:20:43.879 --> 00:20:48.619
HRSA did not relent. They allowed this manufacturer to audit the covered entity.
00:20:48.799 --> 00:20:53.019
The audit actually took place about seven months ago. We still don't have a response.
00:20:53.219 --> 00:20:57.679
They rode this health center hard to make them submit documents and move along.
00:20:57.819 --> 00:21:03.059
And we're not really sure why suddenly HRSA, which has never issued any position
00:21:03.059 --> 00:21:07.739
of its own on managed care, is now letting a drug manufacturer essentially make up the rules.
00:21:08.079 --> 00:21:12.059
Because if there's no rule from HRSA to look at, what rule is the manufacturer?
00:21:12.199 --> 00:21:19.679
And a lot of states have very vague language on how to prevent a rebate in the MCO space.
00:21:19.679 --> 00:21:24.119
Yeah. In this particular case, during the time period, there was no rule for
00:21:24.119 --> 00:21:27.759
managed care claims at the state level and none at the payer level either.
00:21:27.759 --> 00:21:29.719
So I have two follow-ups with that, right?
00:21:29.819 --> 00:21:34.519
So you're saying that's a potential dispute in the future, maybe against HRSA
00:21:34.519 --> 00:21:38.619
for permitting the audit by the drugmaker in the first instance,
00:21:38.699 --> 00:21:41.979
or even obligating the covered entity in any way to be involved in something
00:21:41.979 --> 00:21:42.799
that's not responsible for.
00:21:42.799 --> 00:21:45.639
So my question is, who is responsible?
00:21:45.859 --> 00:21:48.779
So firstly, what you just said made it seem to me, and correct me if I'm wrong.
00:21:49.299 --> 00:21:54.979
That once a covered entity chooses to purchase a 340B drug, the rebateability
00:21:54.979 --> 00:21:57.219
of the drug is extinguished.
00:21:57.339 --> 00:22:01.899
So therefore, the state can't request a rebate once the covered entity chooses to purchase the drug.
00:22:01.959 --> 00:22:06.879
Is that right? Well, the state can write laws and impose rules on when a 340B
00:22:06.879 --> 00:22:09.419
entity can use 340B drugs to bill MCOs.
00:22:09.559 --> 00:22:13.259
They can do that through their contracts with the MCOs and tell the MCOs,
00:22:13.339 --> 00:22:16.779
you're going to tell pharmacies they cannot use 340B drugs.
00:22:16.799 --> 00:22:21.819
Or they can issue a statewide regulation or even pass a law that says you can't
00:22:21.819 --> 00:22:25.359
use 340B drugs when you bill managed care. A lot of states haven't done anything.
00:22:26.238 --> 00:22:31.038
There's nothing on the books about how to do it. And you look at each MCO contract
00:22:31.038 --> 00:22:32.918
or manual and there's nothing there.
00:22:33.078 --> 00:22:37.218
It's so hard to find information. I know we work with health centers all over
00:22:37.218 --> 00:22:43.098
the country to find information about even what MCOs, what PBM they're using.
00:22:43.598 --> 00:22:48.278
And sometimes you find a bulletin and it's just posted on a website somewhere.
00:22:48.518 --> 00:22:53.378
And the lawyer will say, this tears up all of my managed care contracts,
00:22:53.378 --> 00:22:56.378
this bulletin that they just posted. There's no notice and comment.
00:22:56.638 --> 00:23:01.058
There was no official process. They just put a notice on the website and now
00:23:01.058 --> 00:23:04.478
I'm supposed to give up $5 million in managed care bill.
00:23:04.618 --> 00:23:08.078
I mean, it hasn't been handled well in many states.
00:23:08.318 --> 00:23:12.118
Some states have, but in many states it was pretty much ignored.
00:23:12.378 --> 00:23:14.938
And then it got to be a bigger problem for manufacturers.
00:23:15.258 --> 00:23:18.278
And I think HRSA doesn't really know what to do at this point.
00:23:18.278 --> 00:23:22.698
Well, so my question is around the manufacturer audit in HRSA,
00:23:22.878 --> 00:23:26.038
I guess it could be looked at one of two ways.
00:23:26.158 --> 00:23:31.518
Either, you know, condoned it or didn't present a strong front to it.
00:23:31.878 --> 00:23:38.338
Is the timing of kind of Chevron deference in HRSA having less of a say,
00:23:38.798 --> 00:23:41.338
potentially, you know, playing into that?
00:23:41.338 --> 00:23:45.678
I mean, this is actually an area where they have some statutory cover,
00:23:45.838 --> 00:23:50.338
where the statute says that they can, manufacturers can audit under the basically
00:23:50.338 --> 00:23:53.538
conditions that the secretary, which is HRSA, allows.
00:23:53.798 --> 00:23:58.178
So they actually had a little bit of strength here where they put out a policy
00:23:58.178 --> 00:24:01.338
in accordance with notice and comment that may actually have some...
00:24:02.283 --> 00:24:07.163
Some legal effect. Now, somebody else could look at it now, post-Chevron means
00:24:07.163 --> 00:24:10.263
a judge could look at it and reach their own interpretation of what that means.
00:24:10.763 --> 00:24:15.763
But I think this, it could have been a political call that, you know,
00:24:15.903 --> 00:24:21.103
this manufacturer has been beat up pretty bad by HHS on the IRA and some other
00:24:21.103 --> 00:24:22.603
things, so let's let them have this.
00:24:22.843 --> 00:24:24.963
It could have just been a poor decision.
00:24:25.303 --> 00:24:28.563
Or it could be a strategic, we're going to move in this direction,
00:24:28.563 --> 00:24:31.943
we're going to start here, maybe they'll sue us, maybe they won't,
00:24:32.023 --> 00:24:33.143
and we'll see what happens.
00:24:33.583 --> 00:24:40.003
I kind of wonder if when it happened, I kind of wondered if HRSA was afraid of lawsuits.
00:24:40.203 --> 00:24:43.923
So that's why they just kind of went with the manufacturers.
00:24:44.163 --> 00:24:49.803
Which is really unfair because the health center had an argument that this manufacturer
00:24:49.803 --> 00:24:53.363
audit should have never been permitted, should have never been allowed to move forward.
00:24:53.363 --> 00:24:58.723
But to spend six figures to be right, you don't get anything back on that.
00:24:58.723 --> 00:25:01.563
It isn't there's no there's no award at the end of that case.
00:25:01.763 --> 00:25:05.963
You just get her to change what it did. They're not going to do that.
00:25:06.443 --> 00:25:10.103
The manufacturer might. But the health center is probably not going to invest.
00:25:11.183 --> 00:25:14.363
Even if they do, that six figures would be patient care money.
00:25:14.523 --> 00:25:17.623
Yeah. Yeah. It's not sitting in a litigation pool somewhere. Yeah.
00:25:18.243 --> 00:25:24.183
Yeah. So what other lawsuits potentially could we be seeing in the next few months?
00:25:24.343 --> 00:25:29.863
We've seen some startling patient definition audit reports from HRSA.
00:25:30.083 --> 00:25:35.283
And just to set the table, last November, the Genesis case comes out of a federal
00:25:35.283 --> 00:25:36.343
court in South Carolina.
00:25:36.643 --> 00:25:40.743
A judge is finally looking at the way HRSA applies the patient definition and
00:25:40.743 --> 00:25:46.023
basically says, I'm okay with this 1996 guidance, but these other location timing
00:25:46.023 --> 00:25:48.883
requirements that you've added on, they're not obvious from the statute.
00:25:49.563 --> 00:25:54.403
And the hope is, great, now we get to just focus on, do we have a patient relationship?
00:25:54.603 --> 00:25:57.543
And if we do, we can use 340B, and if we don't, we can't.
00:25:57.663 --> 00:26:02.463
But we knew HRSA may or may not adopt that entire mindset, but they were probably
00:26:02.463 --> 00:26:05.203
going to have to go back and change something about the way they were applying
00:26:05.203 --> 00:26:08.203
location tests and referral tests and things like that.
00:26:08.203 --> 00:26:14.643
So we knew we wouldn't really get audit reports for a while because the decision comes out in November.
00:26:15.003 --> 00:26:18.163
If people make changes, it's going to be in December, January,
00:26:18.383 --> 00:26:20.623
February, then they have to get picked for an audit.
00:26:20.803 --> 00:26:23.343
And then the audit has to look at that window from that window.
00:26:23.343 --> 00:26:29.143
March 4th. So we finally started getting some of those come shake out of HRSA in September.
00:26:29.503 --> 00:26:34.143
And we have at least a couple, we've seen probably four, but at least two that
00:26:34.143 --> 00:26:39.963
we've worked on firsthand where there is a clear hospital or health center encounter
00:26:39.963 --> 00:26:41.683
for a specific condition.
00:26:41.843 --> 00:26:47.623
They are referred to a specific provider for a care exactly following up that
00:26:47.623 --> 00:26:51.163
prior condition, full record sharing, HRSA says no.
00:26:51.603 --> 00:26:55.743
If that's not a valid referral prescription, I don't know what is because that's
00:26:55.743 --> 00:26:58.583
been a valid prescription since day one in the 340B program.
00:26:58.823 --> 00:27:03.123
I guess my question in those scenarios is covered entity type taken into effect,
00:27:03.363 --> 00:27:09.123
into account, because I mean, I think an argument could be made that certain
00:27:09.123 --> 00:27:15.003
covered entity types have more of a long-standing relationship with the patient,
00:27:15.143 --> 00:27:16.823
and some are more episodic in nature.
00:27:16.983 --> 00:27:22.323
I would say for these cases, it does not appear that they took into account covered entity type.
00:27:22.723 --> 00:27:26.943
For example, the hospital case, you have someone with hypertensive emergency,
00:27:27.103 --> 00:27:30.143
high blood pressure emergency. They treat them in the emergency room.
00:27:30.203 --> 00:27:31.343
They get admitted for a week.
00:27:31.703 --> 00:27:35.103
The doctor comes and rounds on them, and then they refer the patient to that
00:27:35.103 --> 00:27:39.103
same doctor at their private practice that shares records back with the hospital.
00:27:39.323 --> 00:27:43.403
It's hard to get a tighter length than that between the entire episode of care.
00:27:44.123 --> 00:27:49.223
And then we had a health center that was also part of this batch that had the
00:27:49.223 --> 00:27:54.003
usual many, many, many encounters with the patient, but this one prescription
00:27:54.003 --> 00:27:56.423
was an outside provider that they disallowed.
00:27:56.883 --> 00:28:02.383
And I think if they don't change those audit reports after, for those of you
00:28:02.383 --> 00:28:05.503
who don't know, you get a 340B audit report, you get to challenge it,
00:28:05.583 --> 00:28:06.543
then you'll get a final report.
00:28:06.763 --> 00:28:09.963
If they don't change it before the final report, some of these entities are
00:28:09.963 --> 00:28:14.783
going to sue, and they're going to basically just cite Genesis as the basis for their suit.
00:28:14.983 --> 00:28:19.183
And even though Genesis had that footnote that it only applied to Genesis.
00:28:19.743 --> 00:28:23.083
That's relatively common for. Yeah, that's normal, isn't it?
00:28:23.323 --> 00:28:24.523
Well, it's the same federal law.
00:28:24.883 --> 00:28:28.983
Yeah, well, the language is the same for everybody, right?
00:28:29.343 --> 00:28:33.043
Like, OK, that opinion might have applied to Genesis, but it interpreted the term patient.
00:28:33.557 --> 00:28:37.097
Which is only mentioned once in the 340B statute. And, you know,
00:28:37.177 --> 00:28:40.937
the plain meaning of the term. Miriam does not change based upon the entity type.
00:28:41.297 --> 00:28:47.397
Miriam is Miriam is Miriam. So I don't know why HRSA, other than seeking to
00:28:47.397 --> 00:28:51.277
get another bite at the apple, just for my pharmacist, I'm going to back up, all right?
00:28:51.437 --> 00:28:55.237
So 340B is a pricing and purchasing statute, you know, significant discounts.
00:28:55.577 --> 00:28:59.897
And the term patient's mentioned once, and that's what sets the limitation on what you can purchase.
00:29:00.217 --> 00:29:02.457
If it's your patient, you can purchase. If it's not your patient,
00:29:02.457 --> 00:29:05.837
We're talking about a physician-patient relationship, a provider-patient relationship, right?
00:29:06.057 --> 00:29:09.697
We're not talking about provider-patient relationship for every healthcare service
00:29:09.697 --> 00:29:11.557
that ever happened to this person everywhere in the world.
00:29:11.757 --> 00:29:14.697
You just have to have a relationship with your patient. Simple.
00:29:14.817 --> 00:29:15.637
Did you render a service?
00:29:15.957 --> 00:29:20.497
Well, HRS has taken it, as Jason mentioned, and applying it across the world in every way.
00:29:20.597 --> 00:29:24.417
You have to be responsible for everything that ever happens to this patient
00:29:24.417 --> 00:29:25.917
in order to purchase Dr. 340B.
00:29:26.077 --> 00:29:29.837
And that's just not what the term patient means. It doesn't mean,
00:29:29.997 --> 00:29:32.777
you know, everything that ever happens, you have to be responsible for.
00:29:32.857 --> 00:29:37.697
And I would recommend if you're working in this program that everyone go out and read Genesis.
00:29:38.117 --> 00:29:42.517
Even as a non-lawyer, it's really easy to understand. It was written in a way
00:29:42.517 --> 00:29:43.977
that's very approachable.
00:29:44.177 --> 00:29:48.217
Yeah. And it's 33 pages. There are not dense legal concepts in that.
00:29:48.437 --> 00:29:51.257
I didn't have to Google words like I would have had to today. Exactly.
00:29:51.557 --> 00:29:54.137
Because it really all turns on what does the word patient mean?
00:29:54.217 --> 00:29:57.897
Yeah. What did Congress mean when they used it, you know, 30 years ago?
00:29:58.117 --> 00:30:01.577
Yeah. Well, I have a question. So if you go to your doctor, here's a simple question.
00:30:01.877 --> 00:30:05.457
You got to make this fast, man. We are running out of time here. Well, simple.
00:30:05.557 --> 00:30:08.437
When you go to your primary care doctor and then you've been going to your doctor
00:30:08.437 --> 00:30:11.377
and then you go to another doctor, you decide to get a second opinion.
00:30:11.537 --> 00:30:13.797
Does that mean that primary care doctor is no longer your doctor?
00:30:14.590 --> 00:30:18.070
No, she doesn't say no. She's a patient. Pretty obvious.
00:30:18.350 --> 00:30:21.290
But I think the problem is, because this was congressional intent,
00:30:21.530 --> 00:30:25.350
companies are purchasing a lot of drugs and a person wants to reel that back.
00:30:25.670 --> 00:30:27.330
She doesn't have the authority to do that.
00:30:27.710 --> 00:30:30.990
All right. So knowing that we are running tight on time, I'm going to say final
00:30:30.990 --> 00:30:35.870
thoughts on litigation. It could be existing or what we anticipate seeing.
00:30:36.190 --> 00:30:40.110
I mean, from my side, I would say we're going to see a lot more litigation.
00:30:40.230 --> 00:30:44.090
We're going to see some litigation flow through the administrative dispute resolution
00:30:44.090 --> 00:30:47.770
process and be it brought through HRSA and then to federal court.
00:30:48.010 --> 00:30:54.990
And then we will have to see how a new administration will change policy within
00:30:54.990 --> 00:30:57.090
HHS or within HRSA if they do.
00:30:57.270 --> 00:31:00.170
There may not be much change between one administration to the next,
00:31:00.190 --> 00:31:02.110
or there could be significant change.
00:31:02.310 --> 00:31:05.710
But things like the rebate model and other things, we have to see what happens.
00:31:06.110 --> 00:31:08.650
Yeah, I definitely think we're going to see litigation. I think we're going
00:31:08.650 --> 00:31:11.250
to get a lot of administrative dispute resolution. We're going to get a lot
00:31:11.250 --> 00:31:13.730
of manufacturer audits of covered entities.
00:31:14.110 --> 00:31:17.450
So covered entities, hunker down, get your legal counsel.
00:31:17.910 --> 00:31:22.750
The drug makers will be auditing you. But I do think that all the courts agree
00:31:22.750 --> 00:31:27.410
the plain language dictionary definition of terms in a statute is what prevails.
00:31:27.630 --> 00:31:30.950
So we're getting attacked by the government overbroad.
00:31:31.310 --> 00:31:34.570
We're getting attacked by the drug makers trying to insert language into the
00:31:34.570 --> 00:31:36.830
statute where they want to limit 340B purchases.
00:31:37.370 --> 00:31:41.090
A lot of allegation, but I'm confident that the Covenant needs will defend themselves properly.
00:31:41.350 --> 00:31:46.550
I think it's been a great conversation, and I think we're going to see a lot
00:31:46.550 --> 00:31:52.410
more coming down the road as we're especially changing executive administrations.
00:31:52.730 --> 00:31:56.870
And as you said, Jason, so all of this could change tomorrow.
00:31:57.130 --> 00:32:02.490
So it is a point in time, but it's good from a pharmacist's perspective to hear
00:32:02.490 --> 00:32:08.190
an easy explanation of some of these things that are not in our daily vocabulary.
Don’t miss out on critical updates and game-changing strategies. Subscribe to 340Banter today and ensure your FQHC is always a step ahead in 340B compliance.
"A lot of people don't know that pharma filed suit against HRSA in 1996 when the first contract pharmacy guidance came out and they actually pulled it back due to pushback from Ryan White clinics."
340Banter is brought to you by FQHC 340B Compliance, a trusted partner in optimizing 340B Programs for Federally Qualified Health Centers nationwide. Their mission is to provide tailored resources to help health centers secure and optimize their 340B Programs, improving compliance and oversight. For more information, contact us!